about
A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective studyA phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cellsOrofacial pain in cancer: part II--clinical perspectives and management.Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.Cholangiocarcinoma in primary sclerosing cholangitis.Cholangiocarcinoma--current treatment options.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancer.Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma.Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma.Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection.
P2860
Q33360400-034D76EF-F88E-42DE-94FF-D295A32FCAA3Q33360849-8516C13C-46B8-49BD-9F25-036669DB5687Q33368148-4541CF57-6E96-40A6-ACD2-25C1619901C6Q33371325-4CC545DA-66C0-46C7-83F4-AC43AF678F47Q33381056-094539D2-7C74-4895-86B2-CAA15F9D10A9Q33383423-11F57D25-8DC4-4D2E-8D32-8DEC2F486F0AQ33385654-4579CC24-6C57-4C07-9EAE-3D21ADF75D1DQ33394065-C643D16E-CA26-4F3E-A607-B35E31128E81Q33402598-0CDDA014-5BDB-46BE-A037-FC8C33DFD989Q35181089-2ED4246D-8EFE-45FE-BF80-17EA2C35DE75Q36822722-DEB83832-C324-4B80-96C8-40906DD6D19DQ36831528-BFE661C0-70CA-4403-9988-BAE6392E1B0EQ36900063-95B2F08D-1D06-40BF-87DA-6A0B12DB3081Q37586288-575A87E7-A8D3-494D-BC5D-0B380CD5CA73Q37865009-ACC7444D-01B6-4B74-8698-3D192D5B1DB3Q37983498-0EE01210-8DE9-42E9-9D65-499F160BDD20Q38543212-FF62999E-37B4-47A7-A58E-ABC9D38091CCQ39425771-252923FA-720D-42D5-8656-E78DEECBFA6BQ40076769-16B56C4F-1E4B-4E9C-AFE2-8F34CBA323A4Q40772453-0E0D01F6-DC66-423C-B4EA-036D622C8686Q42120798-128508DC-F68C-4EE3-AD25-8091B0CF4A35Q45271181-AB9D236C-6EDA-4794-9F52-80BD475D1176Q53206208-B7F52B1D-80F7-48B3-AF3F-A75081EE1427
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Review of gemcitabine in biliary tract carcinoma.
@ast
Review of gemcitabine in biliary tract carcinoma.
@en
type
label
Review of gemcitabine in biliary tract carcinoma.
@ast
Review of gemcitabine in biliary tract carcinoma.
@en
prefLabel
Review of gemcitabine in biliary tract carcinoma.
@ast
Review of gemcitabine in biliary tract carcinoma.
@en
P356
P1433
P1476
Review of gemcitabine in biliary tract carcinoma.
@en
P2093
Werner Scheithauer
P356
10.1053/SONC.2002.37380
P433
6 Suppl 20
P577
2002-12-01T00:00:00Z